Case Control Study
Copyright ©The Author(s) 2021.
World J Psychiatr. Dec 19, 2021; 11(12): 1301-1313
Published online Dec 19, 2021. doi: 10.5498/wjp.v11.i12.1301
Table 1 Comparisons of the methylation levels across the BDNF regions in the control subjects and suicide victims
TissueStudy group
BDNF region (% methylated)


I1
I2
II
IV
VI
Brain-BA9C4.55 ± 0.454.43 ± 0.398.48 ± 0.913.81 ± 0.323.37 ± 0.30
SV4.15 ± 0.564.28 ± 0.328.78 ± 1.094.03 ± 0.463.05 ± 0.23
P value0.2600.5570.6670.4180.090
Brain-HippocampusC4.76 ± 0.484.16 ± 0.4410.19 ± 0.513.74 ± 0.463.46 ± 0.34
SV4.40 ± 0.394.60 ± 0.4310.30 ± 1.103.66 ± 0.373.52 ± 0.31
P value0.2220.1470.8510.7720.774
BloodC7.81 ± 1.036.83 ± 0.6415.95 ± 1.365.71 ± 0.395.38 ± 0.95
SV7.00 ± 0.805.67 ± 0.5714.26 ± 1.25.54 ± 0.384.80 ± 0.46
P value0.1980.007a0.0670.5210.245
Table 2 BDNF alternative transcript expression in brain Brodmann area 9 and hippocampus in controls and suicide victims
TissueBDNF transcriptTotal
Subjects
P value95%CI
Analyzed
Controls
Suicide victims


n (%)
n (%)
Relative expression
n (%)
Relative expression


BA9NM_170731.430150.050 ± 0.013150.077 ± 0.0240.042a0.001–0.054
NM_170732.435190.139 ± 0.026160.154 ± 0.0360.451-0.026–0.058
NM_170733.338200.162 ± 0.027180.188 ± 0.0440.270-0.022–0.075
NM_17073530150.103 ± 0.019150.095 ± 0.0190.553-0.033–0.018
HippocampusNM_170731.436160.342 ± 0.117200.312 ± 0.0690.630-0.154–0.094
NM_170732.435170.420 ± 0.120180.369 ± 0.0670.428-0.181–0.079
NM_170733.337180.466 ± 0.111190.475 ± 0.0610.878-0.111–0.129
NM_17073536180.399 ± 0.092180.341 ± 0.0730.308-0.171–0.056